On January 24, 2023, our company held a presentation of the innovative ExAblate Neuro technology by INSIGHTEC (Israel) for transcranial MRI-guided focused ultrasound surgical treatment at the RSE "Hospital of the Medical Center of the President's Affairs Administration of the Republic of Kazakhstan" on the Right of Economical Management.
The presentation was attended by R.K. Albaev, Director of the Hospital of the Medical Center of the President's Affairs Administration of the Republic of Kazakhstan, his deputies, heads of structural divisions, and doctors of the center.
MR-guided focused ultrasound (MRgFUS) is the most dynamically developing technology over the last 10 years, and many specialists recognize it as the future in various fields of medicine.
The ExAblate Neuro system is used in many countries across the Americas, Europe, and Asia to treat patients with essential tremor, tremor-dominant Parkinson's disease, and neuropathic pain. Research continues into its application for epilepsy, Alzheimer's disease, certain brain tumors, etc.
Patients are given the opportunity to get rid of tremors and radically improve their quality of life in a single outpatient session without incisions or craniotomy.
Thanks to ultrasound energy focused at a single point, heating and destruction of the target treatment area occurs. MRI allows for careful planning and real-time tissue temperature mapping, which ensures high precision and safety of the procedure, as well as an immediate assessment of the treatment result.
INSIGHTEC is a global innovator in incisionless surgery medical technology and a world leader in MRI-guided focused ultrasound (MRgFUS).
Our company, as the representative of INSIGHTEC in Kazakhstan, implemented a project on the application of MRgFUS in oncology at the Regional Multidisciplinary Center of Oncology and Surgery in Ust-Kamenogorsk (East Kazakhstan Region).
